Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

ConclusionAdjuvant treatment with docetaxel (CD  ≥ 400 mmg/m2) is associated with a significant rate of grade 2 PA, leading to wearing a wig, in around 10% of patients. This toxicity was completely prevented with scalp cooling. Clinical Trial Reference: NCT00515762.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research